Global Small Animal Imaging (In-vivo) Market Size By Type (Micro-MRI, Optical), By Application (Monitoring Treatment Response, Bio-distribution), By Region, And Segment Forecasts, 2023 to 2032

The Global Small Animal Imaging (In-vivo) Market was valued at USD 1.3 billion in 2023 and is expected to reach USD 2.4 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. Small animal imaging, used predominantly in preclinical research, plays a critical role in visualizing biological processes in living organisms. It enables researchers to track disease progression, study gene expression, and evaluate drug responses non-invasively. The market is experiencing robust growth due to rising investments in pharmaceutical R&D, increasing demand for non-invasive imaging technologies, and the expanding applications of molecular imaging in oncology, neurology, and cardiology research.

Drivers:

1. Increasing Preclinical Research Activities:

The rising demand for new drug discovery and personalized medicine is driving pharmaceutical and biotech companies to increase preclinical studies. Small animal imaging provides critical insights into biological processes, aiding in effective compound screening and validation.

2. Technological Advancements in Imaging Modalities:

Ongoing innovation in imaging systems—such as integration of PET/MRI, SPECT/CT, and optical imaging—enhances resolution, sensitivity, and throughput. These improvements are contributing significantly to the adoption of in-vivo imaging technologies.

3. Rising Focus on Cancer and Neurological Disease Research:

With cancer and neurological disorders becoming leading areas of research, imaging tools that provide real-time insights into disease mechanisms are in high demand. Small animal models are pivotal for studying tumor development and neurodegenerative processes.

Restraints:

1. High Equipment and Maintenance Costs:

Small animal imaging systems involve high capital investment and require specialized infrastructure and skilled professionals, limiting their adoption across smaller research labs and institutions.

2. Regulatory Challenges and Ethical Concerns:

The use of live animals in research is subject to stringent ethical guidelines and regulatory approvals. This can delay research timelines and deter new entrants from adopting these systems.

Opportunity:

1. Growing Adoption in Academic and CRO Settings:

Academic institutions and contract research organizations (CROs) are increasingly investing in small animal imaging systems to enhance their research capabilities. The trend of outsourcing preclinical studies to CROs provides lucrative growth opportunities.

2. Integration of AI for Image Analysis:

The incorporation of artificial intelligence and machine learning in imaging analytics is accelerating the interpretation of complex datasets, improving precision, and reducing analysis time. This advancement is expected to expand the market's scope in drug development.

Market by System Type Insights:

By system type, the Micro-PET segment dominated the market in 2023 due to its superior sensitivity in detecting functional changes at the molecular level. The Micro-CT segment is anticipated to grow at a substantial rate during the forecast period, owing to its high-resolution anatomical imaging capabilities and affordability compared to hybrid modalities.

Market by End-use Insights:

In terms of end-use, Pharmaceutical & Biotechnology Companies held the largest market share in 2023, driven by the increasing number of drug development projects and the need for rapid in-vivo screening tools. The Academic and Research Institutes segment is projected to experience the fastest growth due to rising research funding and collaborations with imaging technology providers.

Market by Regional Insights:

North America led the global small animal imaging market in 2023, supported by a robust biomedical research infrastructure, availability of funding, and presence of key market players. However, Asia-Pacific is poised to witness the fastest growth, attributed to increasing R&D expenditure, emerging biotech sectors, and government support for advanced research in countries like China, India, and Japan.

Competitive Scenario:

Key players in the market include PerkinElmer, Inc., Bruker Corporation, FUJIFILM VisualSonics Inc., Mediso Ltd., MILabs B.V., LI-COR Biosciences, and Aspect Imaging. These companies focus on product development, integration of hybrid modalities, and strategic partnerships with academic institutions.

Key Market Developments:

In 2023, Bruker Corporation launched its next-generation preclinical PET/MRI scanner with enhanced quantification capabilities for oncology research.

FUJIFILM VisualSonics announced a collaboration in 2024 with a major cancer research institute to expand its line of high-frequency ultrasound systems.

In 2025, PerkinElmer introduced a cloud-based image analytics platform powered by AI for high-throughput small animal imaging applications.

Scope of Work – Global Small Animal Imaging (In-vivo) Market

Report Metric Details

Market Size (2023) USD 1.3 Billion

Projected Market Size (2031) USD 2.4 Billion

CAGR (2023–2031) 8.1%

Market Segments By System Type (Micro-PET, Micro-MRI, Micro-CT, etc.), By End-use (Pharma & Biotech, Academic, CROs), By Region

Growth Drivers Rising Preclinical Research, Technological Advancements, Focus on Cancer Research

Opportunities AI-Based Analytics, Increased CRO and Academic Adoption

FAQs:

1) What is the current market size of the Global Small Animal Imaging (In-vivo) Market?

The market was valued at USD 1.3 billion in 2023.

2) What is the major growth driver of the Global Small Animal Imaging (In-vivo) Market?

The primary growth driver is the rising demand for non-invasive, high-resolution imaging technologies in preclinical research.

3) Which is the largest region during the forecast period in the Global Small Animal Imaging (In-vivo) Market?

North America held the largest market share in 2023.

4) Which segment accounted for the largest market share in Global Small Animal Imaging (In-vivo) Market?

The Micro-PET system segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Small Animal Imaging (In-vivo) Market?

Key players include PerkinElmer, Bruker Corporation, FUJIFILM VisualSonics, Mediso, MILabs, LI-COR Biosciences, and Aspect Imaging.